Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
May Measurement Month 2019: an analysis of blood pressure screening results from Malaysia.
Chia YC, Devaraj NK, Chook JB, Chew MT, Ooi PB, Mohamed M, Draman N, Ng WL, Gani AHM, Thiagarajan N, Zulghaffar Z, Beaney T, Day E, Poulter NR, Ching SM. Chia YC, et al. Among authors: day e. Eur Heart J Suppl. 2021 May 20;23(Suppl B):B98-B100. doi: 10.1093/eurheartj/suab058. eCollection 2021 May. Eur Heart J Suppl. 2021. PMID: 34054370 Free PMC article.
May Measurement Month 2019: an analysis of blood pressure screening results from Spain.
Molinero A, Calvo E, Beaney T, Day E, Prats-Mas R, Fornos JA, Mera-Gallego I, Tous S, de Andrés NF, Rodilla E, Gijón T, Pérez-Manchon D, Poulter NR, Ruiz-Hurtado G, Ruilope LM. Molinero A, et al. Among authors: day e. Eur Heart J Suppl. 2021 May 20;23(Suppl B):B138-B140. doi: 10.1093/eurheartj/suab060. eCollection 2021 May. Eur Heart J Suppl. 2021. PMID: 34248438 Free PMC article.
Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study.
Day E, Prevost AT, Sydes MR, Reddy D, Shah TT, Winkler M, Dudderidge T, Staffurth J, McCracken S, Khoo V, Jadav P, Klimowska-Nassar N, Sasikaran T, Ahmed HU, Fiorentino F. Day E, et al. Trials. 2021 Aug 18;22(1):547. doi: 10.1186/s13063-021-05509-w. Trials. 2021. PMID: 34407860 Free PMC article. Clinical Trial.
Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE).
de la Rosa CN, Krell J, Day E, Clarke A, Reddi M, Webber L, Fiorentino F. de la Rosa CN, et al. Among authors: day e. Trials. 2022 Jan 5;23(1):13. doi: 10.1186/s13063-021-05669-9. Trials. 2022. PMID: 34986897 Free PMC article. Clinical Trial.
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial.
Reddy D, Shah TT, Dudderidge T, McCracken S, Arya M, Dobbs C, Emberton M, Fiorentino F, Day E, Prevost AT, Staffurth J, Sydes M, Winkler M, Ahmed HU. Reddy D, et al. Among authors: day e. Contemp Clin Trials. 2020 Jun;93:105999. doi: 10.1016/j.cct.2020.105999. Epub 2020 Apr 14. Contemp Clin Trials. 2020. PMID: 32302790
Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study.
Eldred-Evans D, Burak P, Connor MJ, Day E, Evans M, Fiorentino F, Gammon M, Hosking-Jervis F, Klimowska-Nassar N, McGuire W, Padhani AR, Prevost AT, Price D, Sokhi H, Tam H, Winkler M, Ahmed HU. Eldred-Evans D, et al. Among authors: day e. JAMA Oncol. 2021 Mar 1;7(3):395-402. doi: 10.1001/jamaoncol.2020.7456. JAMA Oncol. 2021. PMID: 33570542 Free PMC article.
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.
Connor MJ, Shah TT, Smigielska K, Day E, Sukumar J, Fiorentino F, Sarwar N, Gonzalez M, Falconer A, Klimowska-Nassar N, Evans M, Naismith OF, Thippu Jayaprakash K, Price D, Gayadeen S, Basak D, Horan G, McGrath J, Sheehan D, Kumar M, Ibrahim A, Brock C, Pearson RA, Anyamene N, Heath C, Shergill I, Rai B, Hellawell G, McCracken S, Khoubehi B, Mangar S, Khoo V, Dudderidge T, Staffurth JN, Winkler M, Ahmed HU. Connor MJ, et al. Among authors: day e. BMJ Open. 2021 Feb 25;11(2):e042953. doi: 10.1136/bmjopen-2020-042953. BMJ Open. 2021. PMID: 33632752 Free PMC article.
PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study.
Bass EJ, Klimowska-Nassar N, Sasikaran T, Day E, Fiorentino F, Sydes MR, Winkler M, Arumainayagam N, Khoubehi B, Pope A, Sokhi H, Dudderidge T, Ahmed HU. Bass EJ, et al. Among authors: day e. Contemp Clin Trials. 2021 Aug;107:106485. doi: 10.1016/j.cct.2021.106485. Epub 2021 Jun 15. Contemp Clin Trials. 2021. PMID: 34139356 Free PMC article. Clinical Trial.
IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis.
Vergis N, Patel V, Bogdanowicz K, Czyzewska-Khan J, Fiorentino F, Day E, Cross M, Foster N, Lord E, Goldin R, Forrest E, Thursz M. Vergis N, et al. Among authors: day e. Trials. 2021 Nov 11;22(1):792. doi: 10.1186/s13063-021-05719-2. Trials. 2021. PMID: 34763711 Free PMC article.
684 results